J&J likely to seek EU approval for COVID-19 vaccine in February - lawmaker
By Francesco Guarascio BRUSSELS (Reuters) - U.S. firm Johnson & Johnson is likely to apply for EU approval for its COVID-19 vaccine candidate in February, a top lawmaker said on Wednesday.
COVID-19 vaccine in February - lawmaker" src="https://images.firstpost.com/wp-content/uploads/reuters/01-2021/14/2021-01-13T120748Z_1_LYNXMPEH0C0UL_RTROPTP_2_HEALTH-CORONAVIRUS-VACCINE-USA.jpg" alt="JJ likely to seek EU approval for COVID19 vaccine in February lawmaker" width="300" height="225" />
By Francesco Guarascio
BRUSSELS (Reuters) - U.S. firm Johnson & Johnson is likely to apply for EU approval for its COVID-19 vaccine candidate in February, a top lawmaker said on Wednesday.
Clinical data of the vaccine, which Johnson & Johnson is developing through its subsidiary Janssen, have been assessed by the European Medicines Agency (EMA) since Dec. 1 under a rolling review to speed up possible approval.
"EU Health Commissioner Stella Kyriakides announced during our (EU lawmakers) group meeting this morning that the vaccine manufacturer Johnson & Johnson is likely to submit an application for approval to the EU for their vaccine in February," said Peter Liese, who represents health matters for the EU's centre-right group, the assembly's largest.
A spokesman for Kyriakides said later on Wednesday: "We cannot give any precise indications regarding an application for conditional marketing authorisation, but we of course hope that an application could be submitted in the coming weeks."
"A date for submission of a marketing authorisation application has not yet been confirmed," EMA said later on Wednesday.
Johnson & Johnson did not immediately respond to a request for comment.
The possible approval timeline in the EU appears to be slightly slower than that expected in the United States.
Moncef Slaoui, chief advisor to the U.S. government's Operation Warp Speed, said at a media briefing on Tuesday that he expected Johnson & Johnson to apply for U.S. emergency authorization by the end of January, which could lead to approval by mid-February.
The EU drugs regulator had said in December it expected the company to apply in the first quarter of this year.
It took EMA 20 days to approve the vaccine developed by BioNTech and Pfizer, and just over a month to authorise the Moderna shot after their applications in early December. The two shots are so far the only ones approved in the EU, while AstraZeneca submitted its application on Tuesday.
"If all goes well, we will already have the fourth corona vaccine available in a few weeks," Liese added.
The EU has booked 200 million doses of the J&J vaccine and has an option to order another 200 million shots. The J&J jab is single dose, unlike other vaccines approved so far in the EU and which require two doses for full protection.
The EU has invested about 360 million euros ($438 million) to secure the J&J vaccine with a downpayment that would need to be complemented with payments by EU governments willing to buy the vaccine after approval.
The U.S. government secured 100 million doses from the company for $1 billion in an August agreement, with an option to buy an additional 200 million doses.
($1 = 0.8216 euros)
(Reporting by Francesco Guarascio @fraguarascio; additional reporting by Rebecca Spalding; editing by Jason Neely, Louise Heavens and Bernadette Baum)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Aditya Kalra NEW DELHI (Reuters) - India's tobacco industry will object to a proposal to ban smoking zones in hotels and prohibit advertising at cigarette kiosks as the government steps up anti-smoking efforts, two executives said on Wednesday. India has over the years introduced tobacco controls and launched campaigns to deter its use, but enforcement of the law has been a challenge.
HONG KONG (Reuters) - Over 50 pro-democratic activists in Hong Kong were arrested on Wednesday for breaking the city's contentious national security law, local media reported, in the biggest crackdown yet against the democratic opposition under the new law. The arrests in the Asian financial hub included well known democratic figures and former lawmakers James To, Lam Cheuk Ting and Lester Shum, according to the Democratic Party's Facebook page and public broadcaster RTHK. Police did not immediately respond to requests for comment.
BRASILIA (Reuters) - Brazil's syringe manufacturers said on Tuesday they will supply 30 million syringes and needles for the country's COVID-19 vaccination program after the government said it would requisition surplus supplies. Executives of the three main manufacturers met with President Jair Bolsonaro at the Health Ministry and it was agreed that each would supply 10 million syringes to cover the initial stages of the vaccination plan.